These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7251138)

  • 1. Kinetics of adenosinediphosphoribosylation of elongation factor 2 in cells exposed to diphtheria toxin.
    Moynihan MR; Pappenheimer AM
    Infect Immun; 1981 May; 32(2):575-82. PubMed ID: 7251138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-mediated transport of the hybrid protein ricin-diphtheria toxin fragment A with subsequent ADP-ribosylation of intracellular elongation factor II.
    Youle RJ; Neville DM
    J Biol Chem; 1979 Nov; 254(21):11089-96. PubMed ID: 500625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entry of diphtheria toxin into cells: possible existence of cellular factor(s) for entry of diphtheria toxin into cells was studied in somatic cell hybrids and hybrid toxins.
    Kaneda Y; Uchida T; Mekada E; Nakanishi M; Okada Y
    J Cell Biol; 1984 Feb; 98(2):466-72. PubMed ID: 6693491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-N6-Etheno-ADP-ribosylation of elongation factor-2 by diphtheria toxin.
    Giovane A; Balestrieri C; Quagliuolo L; Servillo L
    FEBS Lett; 1985 Oct; 191(2):191-4. PubMed ID: 2996930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Archaebacterial elongation factor is ADP-ribosylated by diphtheria toxin.
    Kessel M; Klink F
    Nature; 1980 Sep; 287(5779):250-1. PubMed ID: 6776409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of diphtheria-toxin-resistant mutants lacking receptor function or containing nonribosylatable elongation factor 2.
    Kohno K; Uchida T; Mekada E; Okada Y
    Somat Cell Mol Genet; 1985 Sep; 11(5):421-31. PubMed ID: 3862242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diphtheria toxin. Site and configuration of ADP-ribosylation of diphthamide in elongation factor 2.
    Oppenheimer NJ; Bodley JW
    J Biol Chem; 1981 Aug; 256(16):8579-81. PubMed ID: 6267047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eukaryotic elongation factor 2 loses its non-specific affinity for RNA and leaves polyribosomes as a result of ADP-ribosylation.
    Sitikov AS; Davydova EK; Bezlepkina TA; Ovchinnikov LP; Spirin AS
    FEBS Lett; 1984 Oct; 176(2):406-10. PubMed ID: 6208057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the endogenous ADP-ribosylation of wild-type and mutant elongation factor 2 in eukaryotic cells.
    Fendrick JL; Iglewski WJ; Moehring JM; Moehring TJ
    Eur J Biochem; 1992 Apr; 205(1):25-31. PubMed ID: 1313365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of diphtheria toxin fragment A and of elongation factor 2 with cibacron blue.
    Rambelli F; Brigotti M; Sperti S; Montanaro L
    Biosci Rep; 1987 Sep; 7(9):737-43. PubMed ID: 3427221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of protein synthesis inactivation by diphtheria toxin in toxin-resistant L cells. Evidence for a low efficiency receptor-mediated transport system.
    Heagy WE; Neville DM
    J Biol Chem; 1981 Dec; 256(24):12788-92. PubMed ID: 7309737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of ADP-ribosylation of elongation factor 2 catalyzed by fragment A from diphtheria toxin.
    Chung DW; Collier RJ
    Biochim Biophys Acta; 1977 Aug; 483(2):248-57. PubMed ID: 196649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diphthamide in elongation factor 2: ADP-ribosylation, purification, and properties.
    Bodley JW; Dunlop PC; VanNess BG
    Methods Enzymol; 1984; 106():378-87. PubMed ID: 6387379
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduced ribosomal binding of eukaryotic elongation factor 2 following ADP-ribosylation. Difference in binding selectivity between polyribosomes and reconstituted monoribosomes.
    Nygård O; Nilsson L
    Biochim Biophys Acta; 1985 Feb; 824(2):152-62. PubMed ID: 3970930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cytotoxic epidermal growth factor cross-linked to diphtheria toxin A-fragment.
    Shimizu N; Miskimins WK; Shimizu Y
    FEBS Lett; 1980 Sep; 118(2):274-8. PubMed ID: 6252055
    [No Abstract]   [Full Text] [Related]  

  • 16. Recognition of elongation factor 2 by diphtheria toxin is not solely defined by the presence of diphthamide.
    Van Ness BG; Barrowclough B; Bodley JW
    FEBS Lett; 1980 Oct; 120(1):4-6. PubMed ID: 7439387
    [No Abstract]   [Full Text] [Related]  

  • 17. Diphtheria toxin mutant CRM197 possesses weak EF2-ADP-ribosyl activity that potentiates its anti-tumorigenic activity.
    Kageyama T; Ohishi M; Miyamoto S; Mizushima H; Iwamoto R; Mekada E
    J Biochem; 2007 Jul; 142(1):95-104. PubMed ID: 17525101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diphtheria toxin:receptor interaction. Characterization of the receptor interaction with the nucleotide-free toxin, the nucleotide-bound toxin, and the B-fragment of the toxin.
    Proia RL; Eidels L; Hart DA
    J Biol Chem; 1981 May; 256(10):4991-7. PubMed ID: 7228866
    [No Abstract]   [Full Text] [Related]  

  • 19. ADP-ribosylating microbial toxins.
    Foster JW; Kinney DM
    Crit Rev Microbiol; 1985; 11(4):273-98. PubMed ID: 2859967
    [No Abstract]   [Full Text] [Related]  

  • 20. Structure-activity relationships in diphtheria toxin and exotoxin A from Pseudomonas aeruginosa.
    Collier RJ; Gilliland DG; Lory S
    Prog Clin Biol Res; 1979; 31():751-9. PubMed ID: 119972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.